Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …
R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - Elsevier
BACKGROUND: The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …
[HTML][HTML] Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with …
IS Leren, J Saberniak, E Majid, TF Haland… - Heart Rhythm, 2016 - Elsevier
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an
inheritable cardiac disease predisposing to malignant ventricular arrhythmias. Objective We …
inheritable cardiac disease predisposing to malignant ventricular arrhythmias. Objective We …
Catecholaminergic polymorphic ventricular tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a highly malignant form of
arrhythmogenic disorder characterized by exercise-or emotional-induced polymorphic …
arrhythmogenic disorder characterized by exercise-or emotional-induced polymorphic …
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients
M Faggioni, HS Hwang, C van der Werf… - Circulation …, 2013 - Am Heart Assoc
Rationale: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by
mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes. Sinoatrial …
mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes. Sinoatrial …
High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade …
KH Haugaa, IS Leren, KE Berge, J Bathen… - Europace, 2010 - academic.oup.com
Aim Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited cardiac
disease predisposing to life-threatening arrhythmias. We aimed to determine the prevalence …
disease predisposing to life-threatening arrhythmias. We aimed to determine the prevalence …
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia
C van der Werf, PJ Kannankeril, F Sacher… - Journal of the American …, 2011 - jacc.org
Objectives: This study evaluated the efficacy and safety of flecainide in addition to
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …
Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular …
H Watanabe, C van der Werf, F Roses-Noguer, A Adler… - Heart rhythm, 2013 - Elsevier
BACKGROUND: Conventional therapy with beta-blockers is incompletely effective in
preventing arrhythmic events in patients with catecholaminergic polymorphic ventricular …
preventing arrhythmic events in patients with catecholaminergic polymorphic ventricular …
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing
JD Fisher, D Krikler, KA Hallidie-Smith - Journal of the American College of …, 1999 - jacc.org
OBJECTIVES We sought to determine whether objective tests of antiarrhythmic drug efficacy
could produce favorable short-and long-term outcomes in a family with idiopathic malignant …
could produce favorable short-and long-term outcomes in a family with idiopathic malignant …
Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments
C van der Werf, AH Zwinderman, AAM Wilde - Europace, 2012 - academic.oup.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia
syndrome characterized by bidirectional or polymorphic ventricular arrhythmias under …
syndrome characterized by bidirectional or polymorphic ventricular arrhythmias under …
Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial
Importance Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially
lethal genetic arrhythmia syndrome characterized by polymorphic ventricular tachycardia …
lethal genetic arrhythmia syndrome characterized by polymorphic ventricular tachycardia …
相关搜索
- blockers alone ventricular tachycardia
- β blockers ventricular arrhythmias
- sinus rhythm ventricular tachycardia
- arrhythmic events ventricular tachycardia
- flecainide therapy ventricular arrhythmias
- high prevalence ventricular tachycardia
- quarter century ventricular arrhythmias
- flecainide in the treatment ventricular tachycardia
- incidence and severity ventricular arrhythmias
- family members ventricular tachycardia
- risk factors ventricular tachycardia
- beta blockers ventricular tachycardia
- β blockers ventricular tachycardia
- flecainide therapy ventricular tachycardia
- effects of flecainide ventricular arrhythmias
- efficacy of flecainide ventricular tachycardia